Qiagen and Clinical Genomics combined the PAXgene Blood ccfDNA Tube sample collection system into Clinical Genomics' Colvera colorectal cancer recurrence assay.
Here's what you should know:
1. The combined solution is a blood-based test for recurrent tumors circulating in DNA.
2. The test can be conducted by a physician through a "simple blood test."
3. Qiagen's Head of Molecular Diagnostics Business Thierry Bernard said in a release the test is a non-invasive monitoring option for colorectal cancer patients.
4. The test is as effective as market standard tests for recurrent colorectal cancer.
5. The companies established a joint venture company, PreAnalytiX GmbH, to develop the test.